Lorenzen, Sylvie;Götze, Thorsten Oliver;Thuss-Patience, Peter;Biebl, Matthias;Homann, Nils;Schenk, Michael;Lindig, Udo;Heuer, Vera;Kretzschmar, Albrecht;Goekkurt, Eray;Haag, Georg Martin;Riera-Knorrenschild, Jorge;Bolling, Claus;Hofheinz, Ralf-Dieter;Zhan, Tianzuo;Angermeier, Stefan;Ettrich, Thomas Jens;Siebenhuener, Alexander Reinhard;Elshafei, Moustafa;Bechstein, Wolf Otto;Gaiser, Timo;Loose, Maria;Sookthai, Disorn;Kopp, Christina;Pauligk, Claudia;Al-Batran, Salah-Eddin
Perioperative Atezolizumab Plus Fluorouracil, Leucovorin, Oxaliplatin, and Docetaxel for Resectable Esophagogastric Cancer: Interim Results From the Randomized, Multicenter, Phase II/III DANTE/IKF-s633 Trial.
J Clin Oncol
2024
42
4
410-420

Toribio Castello, S. M.;Lopez-Cadenas, F.;Preudhomme, C.;Villaverde Ramiro, A.;Fenwarth, L.;Lumbreras, E.;Gonzalez, T.;Del Rey, M.;Xicoy, B.;Renneville, A.;Sanchez, J.;Coll, R.;Slama, B.;Hernandez Rivas, J. A.;Thepot, S.;Bernal, T.;Guerci-Bresler, A.;Gotze, K.;Hernandez Rivas, J. M.;Fenaux, P.;Del Canizo, C.;Campelo, M.
LONG-TERM MUTATIONAL DYNAMICS IN DEL(5Q) MDS PATIENTS EARLY TREATED WTIH LENALIDOMIDE (SINTRAREV CLINICALTRIAL). SAFE AND EFFECITIVE APPROACH REGARDING CLONAL EVOLUTION?
Leuk Res
2023
128 Suppl S

Joensuu, Heikki;Reichardt, Annette;Eriksson, Mikael;Hohenberger, Peter;Boye, Kjetil;Cameron, Silke;Lindner, Lars H;Jost, Philipp J;Bauer, Sebastian;Schütte, Jochen;Lindskog, Stefan;Kallio, Raija;Jaakkola, Panu M;Goplen, Dorota;Wardelmann, Eva;Reichardt, Peter
Survival of patients with ruptured gastrointestinal stromal tumour treated with adjuvant imatinib in a randomised trial.
Br J Cancer
2024
131
2
299-304

Al-Batran, Salah-Eddin;Lorenzen, Sylvie;Riera, Jorge;Caca, Karel;Mueller, Christian;Stange, Daniel E.;Zander, Thomas;Bolling, Claus;Homann, Nils;Gaedcke, Jochen;Thuss-Patience, Peter C.;Michl, Patrick;Blau, Wolfgang;Wille, Kai;Koch, Christine;Pauligk, Claudia;Mueller, Daniel Wilhelm;Bankstahl, Ulli Simone;Moenig, Stefan Paul;Goetze, Thorsten
Effect of chemotherapy/targeted therapy alone vs. chemotherapy/targeted therapy followed by radical surgical resection on survival and quality of life in patients with limited-metastatic adenocarcinoma of the stomach or esophagogastric junction: The IKF-575/RENAISSANCE phase III trial.
J Clin Oncol
2024
42 Suppl 17_SUPPL
17_SUPPL
LBA4001-LBA4001

Tintelnot, Joseph;Stein, Alexander;Al-Batran, Salah-Eddin;Ettrich, Thomas;Götze, Thorsten;Grün, Barbara;Haag, Georg Martin;Heuer, Vera;Hofheinz, Ralf-Dieter;Homann, Nils;Bröring, Tobias Sebastian;Cruz, Mariana Santos;Kurreck, Annika;Lorenzen, Sylvie;Moosmann, Nicolas;Müller, Christian;Schuler, Markus;Siegler, Gabriele;Binder, Mascha;Gökkurt, Eray
Pembrolizumab and trastuzumab in combination with FLOT in the perioperative treatment of HER2-positive, localized esophagogastric adenocarcinoma-a phase II trial of the AIO study group (AIO STO 0321).
Front Oncol
2023
13

Stocker, G;Lorenzen, S;Ettrich, T;Herz, A-L;Longo, F;Kiani, A;Venerito, M;Trojan, J;Mahlberg, R;Moosmann, N;Chibaudel, B;Kubicka, S;Greil, R;Daum, S;Geissler, M;Larcher-Senn, J;Keller, G;Lordick, F;Haag, G M
S-1 maintenance therapy in Caucasian patients with metastatic esophagogastric adenocarcinoma-final results of the randomized AIO MATEO phase II trial.
ESMO Open
2023
8
3

Nachtkamp, K.;Vukelja, M.;Strupp, C.;Kasprzak, A.;Baldus, S.;Rudelius, M.;Aul, C.;Pfeilstoecker, M.;Valent, P.;Hofmann, W. -K;Schuette, H. J.;Blum, S.;Haase, D.;Krieger, O.;Luebbert, M.;Stauder, R.;Schlenk, R.;Goetze, K.;Lipke, J.;Beier, F.;Giagounidis, A.;Dietrich, S.;Hildebrandt, B.;Betz, B.;Gattermann, N.;Germing, U.
Applicability of the new WHO Classification for the MDS: Data from the Dusseldorf MDS Registry
Oncology Research and Treatment
2023
46 Suppl 5
205-205

Rautenberg, Christina;Stelljes, Matthias;Acker, Fabian;Holtick, Udo;Jost, Edgar;Schliemann, Christoph;Ragette, Anja;Kaivers, Jennifer;Neuendorff, Nina;Hanoun, Maher;Schmalbrock, Laura K.;Braitsch, Krishan;Verbeek, Mareike;Goetze, Katharina;Bug, Gesine;Reinhardt, Christian;Kroeger, Nicolaus;Schroeder, Thomas
VENETOCLAX AND HYPOMETHYLATING AGENTS FOLLOWED BY ALLOGENEIC STEM CELL TRANSPLANTATION IN PATIENTS WITH ACUTE MYELOID LEUKEMIA
Bone Marrow Transplant
2023
58 Suppl 1
SUPP1
163-163

Kuehn, Julia C;Metzger, Patrick;Neidert, Nicolas;Matysiak, Uta;Gräßel, Linda;Philipp, Ulrike;Bleul, Sabine;Pauli, Thomas;Falkenstein, Julia;Bertemes, Henriette;Cysar, Stepan;Hess, Maria Elena;Frey, Anna Verena;Duque-Afonso, Jesús;Schorb, Elisabeth;Machein, Marcia;Beck, Jürgen;Schnell, Oliver;von Bubnoff, Nikolas;Illert, Anna L;Peters, Christoph;Brummer, Tilman;Prinz, Marco;Miething, Cornelius;Becker, Heiko;Lassmann, Silke;Werner, Martin;Börries, Melanie;Duyster, Justus;Heiland, Dieter H;Sankowski, Roman;Scherer, Florian
Comprehensive genetic profiling and molecularly guided treatment for patients with primary CNS tumors.
npj Precis Oncol
2024
8
1

Rassner, Michael;Waldeck, Silvia;Follo, Marie;Jilg, Stefanie;Philipp, Ulrike;Jolic, Martina;Wehrle, Julius;Jost, Philipp J;Peschel, Christian;Illert, Anna Lena;Duyster, Justus;Scherer, Florian;von Bubnoff, Nikolas
Development of Highly Sensitive Digital Droplet PCR for Detection of cKIT Mutations in Circulating Free DNA That Mediate Resistance to TKI Treatment for Gastrointestinal Stromal Tumor (GIST).
Int J Mol Sci
2023
24
6